Nevirapine Extended Release | Nevirapine Tablet Breastfeeding

There are high number of clear evidence that breastfeeding provides best nutrition that you can give to your baby. It is also evident that lactation is good for mothers health as well. Evolution has designed breastfeeding in a way that it caters all nutritional need of your child. However modern medicine is quite new for evolution, that is why mothers body is not well prepared to filter unnecessary chemical found in medicines. It becomes a necessity to figure out which drug is safe and which drug is dangerous for your newborn while nursing. In this article we will understand function of Nevirapine Extended Release | Nevirapine Tablet and its suitability with breastfeeding.

What is Nevirapine Extended Release | Nevirapine Tablet used for?


Nevirapine extended-release tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adults and pediatric patients 6 years of age or older with a body surface area (BSA) of 1.17 m2 or greater [see Clinical Studies (14.1, 14.2)]. Limitations of Use: Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, nevirapine extended-release tablets are not recommended to be initiated, unless the benefit outweighs the risk, in: adult females with CD4+ cell counts greater than 250 cells/mm3 or adult males with CD4+ cell counts greater than 400 cells/mm3 [ see Warnings and Precautions (5.1)]. Nevirapine extended-release tablets are an NNRTI indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in adults and pediatric patients 6 years of age or older with a BSA of 1.17 m2 or greater. (1) Limitations of Use: Based on serious and life-threatening hepatotoxicity observed in controlled and uncontrolled trials, nevirapine extended-release tablets are not recommended to be initiated, unless the benefit outweighs the risk, in: adult females with CD4+ cell counts greater than 250 cells/mm3 adult males with CD4+ cell counts greater than 400 cells/mm3 (1, 5.1)

Is using Nevirapine Extended Release | Nevirapine Tablet unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Nevirapine Extended Release | Nevirapine Tablet low risk for breastfeeding
Nevirapine is the one and only active ingredient present in Nevirapine Extended Release | Nevirapine Tablet. Nevirapine in itself is a low risk drug for lactation so it is easy to understand that Nevirapine Extended Release | Nevirapine Tablet also comes in category of Low Risk item while breastfeeding. Below is the summary of Nevirapine in breastfeeding.

Nevirapine Extended Release | Nevirapine Tablet Breastfeeding Analsys


Nevirapine while Breastfeeding

Low Risk

CAS Number: 129618-40-2

Anti-HIV drug. It has been used to treat neonates for vertical transmission risk lowering. Mothers must be adviced that transmission of HIV infection through breastfeeding has been documented.


Nevirapine Extended Release | Nevirapine Tablet Breastfeeding Analsys - 2


Nevirapine while Breastfeeding

CAS Number: 129618-40-2

Is Nevirapine Extended Release | Nevirapine Tablet safe while breastfeeding

In the United States and other developed countries, HIV-infected mothers should generally not breastfeed their infants. Nevirapine has been well studied in nursing mothers. In countries in which no acceptable, feasible, sustainable and safe replacement feeding is available, World Health Organization guidelines recommend that all women with an HIV infection who are pregnant or breastfeeding should be maintained on antiretroviral therapy for at least the duration of risk for mother-to-child transmission. Mothers should exclusively breastfeed their infants for the first 6 months of life; breastfeeding with complementary feeding should continue through 12 months of life. The first choice regimen for nursing mothers is tenofovir, efavirenz and either lamivudine or emtricitabine. If these drugs are unavailable, alternative regimens include: 1) zidovudine, lamivudine and efavirenz; 2) zidovudine, lamivudine and nevirapine; or 3) tenofovir, nevirapine and either lamivudine or emtricitabine. Exclusively breastfed infants should also receive 6 weeks of prophylaxis with nevirapine.[1][2] Because of the long half-life of nevirapine, subtherapeutic nevirapine concentrations can persist in breastmilk and infant serum for relatively long periods, potentially increasing the risk of development of nevirapine-resistant HIV infections when it is used alone for prophylaxis in the mother.[3][4][5][6][7][8]



What should I do if I am breastfeeding mother and I am already exposed to Nevirapine Extended Release | Nevirapine Tablet?

Nevirapine Extended Release | Nevirapine Tablet is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Nevirapine Extended Release | Nevirapine Tablet so you should inform him based on your convenience.


My health care provider has asked me to use Nevirapine Extended Release | Nevirapine Tablet, what to do?

Nevirapine Extended Release | Nevirapine Tablet comes in category of low risk and if your doctor is aware that you are breastfeeding it should be ok to use without much concerns.


If I am using Nevirapine Extended Release | Nevirapine Tablet, will my baby need extra monitoring?

Not much monitoring required while using Nevirapine Extended Release | Nevirapine Tablet


Who can I talk to if I have questions about usage of Nevirapine Extended Release | Nevirapine Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week